Physician Wealth Advisors’s Vaxcyte PCVX Stock Holding History

Physician Wealth Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.45K	Buy	43 +18	+72%	+$1.05K	﹤0.01%	1480
2026 Q2	$1.45K	Sell	25 -69	-73%	-$3.75K	﹤0.01%	1654
2026 Q1	$5.46K	Sell	94 -2	-2%	-$109	﹤0.01%	981
2025 Q4	$4.43K	Buy	96 +9	+10%	+$403	﹤0.01%	1006
2025 Q3	$3.13K	Buy	87 +26	+43%	+$861	﹤0.01%	1055
2025 Q2	$1.98K	Buy	61 +47	+336%	+$1.54K	﹤0.01%	1046
2025 Q1	$529	Buy	+14	New	+$1.12K	﹤0.01%	1360

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Physician Wealth Advisors's PCVX Position: Q3 2026 in Review

Physician Wealth Advisors increased its Vaxcyte (PCVX) stake by 72% in Q3 2026, buying an estimated $1.05K and bringing the position to 43 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Physician Wealth Advisors first reported a position in PCVX in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.46K in Q1 2026. 167 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

Physician Wealth Advisors held 43 shares of Vaxcyte worth $2.45K as of Q3 2026.
Physician Wealth Advisors bought 18 Vaxcyte shares in Q3 2026, an estimated $1.05K.
Vaxcyte made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1480 holding.
Physician Wealth Advisors first reported a position in Vaxcyte in Q1 2025 and has held it in 7 quarters since.
Physician Wealth Advisors's Vaxcyte position peaked at $5.46K in Q1 2026.
167 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.